Summary:
FTO Antibody Blocking Peptide
Cat：K110456P-Ag
| 【Derived From】： Synthetic |
| 【Amino Acid】： 190-240/505aa |
| 【Uniprot】： Q9C0B1 |
| 【Gene ID】： 79068 |
| 【Application】： Blocking Peptide of K110456P Antibody |
| 【Purification】： HPLC |
| 【Bioactive】： Not tested |
Store:
| 【Storage】： Store at -20℃，2 years.Avoid freeze/thaw cycles. |
| 【Formulation】： Lyophilized powder |
Background:
RNA demethylase that mediates oxidative demethylation of different RNA species， such as mRNAs， tRNAs and snRNAs， and acts as a regulator of fat mass， adipogenesis and energy homeostasis (PubMed:22002720， PubMed:26458103， PubMed:28002401， PubMed:30197295， PubMed:26457839， PubMed:25452335). Specifically demethylates N6-methyladenosine (m6A) RNA， the most prevalent internal modification of messenger RNA (mRNA) in higher eukaryotes (PubMed:22002720， PubMed:26458103， PubMed:30197295， PubMed:26457839， PubMed:25452335). M6A demethylation by FTO affects mRNA expression and stability (PubMed:30197295). Also able to demethylate m6A in U6 small nuclear RNA (snRNA) (PubMed:30197295). Mediates demethylation of N6，2’-O-dimethyladenosine cap (m6A(m))， by demethylating the N6-methyladenosine at the second transcribed position of mRNAs and U6 snRNA (PubMed:28002401， PubMed:30197295). Demethylation of m6A(m) in the 5’-cap by FTO affects mRNA stability by promoting susceptibility to decappi
Verified picture
